Demis Hassabis, CEO of DeepMind, revealed that AI can drastically shorten drug discovery timelines, potentially reducing ...

It wasn’t always this way. Leveraging AI in drug development is not only thanks to growing access to semiconductor chips, but ...

Drug use among young people in Ghana is no longer a hidden problem . What was once limited to alcohol and cigarettes has now ...

Pharmaceutical Technology serves as the connection to bio manufacturing and development, featuring regulatory updates and ...

Millions in military and development funds for Colombia hang in the balance as Washington questions the country’s fight ...

Impurities and instability are challenges for all drugs, but a growing range of technological tools are helping drug developers and manufacturers minimize them.

New draft guidelines suggest the FDA is open to exercising regulatory flexibility for non-opioid drugs being developed for chronic pain.

NEW HAVEN, CT / ACCESS Newswire / September 4, 2025 / Revalia Bio Inc., announced a 14.5M seed funding round to support their ...

The American Hospital Association is asking the Federal Trade Commission and the Department of Justice to get involved in the ...

The Bulk Drug Park in Una, Himachal Pradesh, has received environmental clearance, enabling its development to reduce ...

Instead of Red No. 40, Yellow No. 5 and Yellow No. 6, the snacks will be colored with a mix of beets, radishes, paprika, ...

Sagimet Biosciences Inc. (Sagimet, Nasdaq: SGMT), a clinical-stage biopharmaceutical company developing novel therapeutics targeting dysfunctional metabolic and fibrotic pathways, today announced that ...